. Author manuscript; available in PMC: 2013 Aug 1.

Published in final edited form as: Pharmacogenomics J. 2011 Aug 16;13(1):35–43. doi: 10.1038/tpj.2011.38

Table 1.

Characteristics and mean responses to carboplatin and cisplatin of the HapMap panels included in the meta-analyses.

	YRI1/2	YRI3	ASW	CHD	ASN	CEU1/2	CEU3
N	90	86	83	85	90	90	84
family structure	30 trios	27 trios, 1 duo, 3 singletons	10 trios, 20 duos, 13 singletons	unrelated	unrelated	30 trios	22 trios, 5 duos, 8 singletons
carboplatin IC₅₀¹ (μM)	30.0 (17.4)	36.8 (14.1)	20.1 (7.1)	25.1 (23.7)	19.7 (8.2)	24.5 (13.9)	28.2 (14.0)
cisplatin IC₅₀¹ (μM)	8.3 (6.5)	10.2 (6.1)	4.6 (4.1)	6.7 (11.5)	4.5 (3.7)	7.8 (8.5)	8.1 (5.6)

mean (SD)